Who is not suitable for monoravir capsules (molnupiravir)

Molnupiravir capsules (Molnupiravir) is a drug used to treat COVID-19, but it is not suitable for all people. The following are some groups of people who are not suitable for using monogravir capsules:

1.Pregnant and lactating women: The safety of monogravir capsules has not been fully studied in pregnant and lactating women. Due to potential risks to the fetus or infant, use by pregnant and nursing women should be avoided except under close supervision by a physician and when the potential benefits of treatment outweigh the potential risks.

2.Children: Currently, clinical trials of monogravir capsules are mainly conducted on adult patients. Therefore, it has not been approved for use in children. More research and data are needed for use in children to ensure safety and effectiveness.

3.Patients with severe liver disease: Patients with severe liver disease should avoid the use of monogravir capsules as drug metabolism may be impaired, increasing the risk of side effects. In this case, the doctor may choose other treatment options.

4.History of drug allergy: If the patient has a history of allergic reaction to the ingredients of monogravir capsules or similar drugs, the use of this drug may cause a serious allergic reaction. Patients should inform their doctor about their drug allergies before use.

5.Other potential special conditions: For certain special conditions, such as severe heart disease, kidney problems, immune system suppression, etc., patients should use monogravir capsules under the advice of their doctor. Doctors will evaluate whether this drug is suitable for use based on the patient's specific situation.

Monolavir capsules are already on the market in China, but are not yet included in medical insurance. Please consult your local hospital pharmacy for specific prices. The cheaper ones abroad are Indian generic drugs, which cost around three to four hundred yuan, and the ingredients of domestic original drugs and foreign generic drugs are basically the same.